Effect of glutamine on Th1 and Th2 cytokine responses of human peripheral blood mononuclear cells

Clinical Immunology

Volumn 93, Issue 3, 1999, Pages 294-301

  Chang, Wei Kuo ^a   Yang, Kuender D ^b   Shaio, Men Fang ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Bacillus Calmette Guerin; Glutamine; Measles virus; Th1 Th2 cells

Indexed keywords

BCG VACCINE; CYTOKINE; GAMMA INTERFERON; GLUTAMINE; MEASLES VACCINE;

AMINO ACID BLOOD LEVEL; ARTICLE; CATABOLISM; CONTROLLED STUDY; CYTOKINE RELEASE; HELPER CELL; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MONONUCLEAR CELL; PRIORITY JOURNAL;

EID: 0032804665     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.1999.4788     Document Type: Article

References (41)

1. Askanazi J., Carpentier Y. A., Michelsen C. B., Elwyn D. H., Furst P., Kantrowitz L. R., Gump F. E., Kinney J. M. Muscle and plasma amino acids following injury. Ann. Surg. 192:1980;78-85.
2. Newsholme E. A., Parry-Billings M. Properties of glutamine release from muscle and its importance for the immune system. J. Parenter. Enter. Nutr. 14:1990;63S-67S.
3. Roth E., Karner J., Ollenschlager G. Glutamine: An anabolic effector? J. Parenter. Enter. Nutr. 14:1990;130S-136S.
4. Newsholme E. A. The possible role of glutamine in some cells of the immune system and the possible consequence for the whole animal. Experientia. 52:1996;455-459.
5. Gore D. C., Jahoor F. Glutamine kinetics in burn patients: comparison with hormonally induced stress in volunteers. Arch. Surg. 129:1994;1318-1323.
6. Parry-Billings M., Evans J., Clader P. C., Newsholme E. A. Does glutamine contribute to immunosuppression after major burns? Lancet. 336:1990;523-525.
7. Rohde T., Maclean D. A., Pedersen B. K. Glutamine, lymphocyte proliferation and cytokine production. Scand. J. Immunol. 44:1996;648-650.
8. Horig H., Spagnoli G. C., Filguerira L., Babst R., Gallati H., Harder F., Juretic A., Heberer M. Exogenous glutamine requirement is confined to late events of T cell activation. J. Cell. Biochem. 53:1993;343-351.
9. Klimberg V. S., McClellan J. L. Glutamine, cancer, and its therapy. Am. J. Surg. 172:1996;418-424.
10. Yaqoob P., Calder P. C. Glutamine requirement of proliferating T lymphocytes. Biochem. Soc. Trans. 24:1996;78S.
11. Rohde H., Ullum H., Rasmussen J. P., Kristensen J. H., Newsholme E., Pedersen B. K. Effects of glutamine on the immune system: Influence of muscular exercise and HIV infection. J. Appl. Physiol. 79:1995;146-150.
12. Puri S., Chandra R. K. Nutritional regulation of host resistance and predictive value of immunologic tests in assessment of outcome. Pediatr. Clin. North Am. 32:1985;499-516.
13. Ziegler T. R., Young L. S., Benfell K., Scheltinga M., Hortos K., Bye R., Morrow F. D., Jacobs D. O., Smith R. J., Antin J. H., Wilmore D. W. Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. Ann. Intern. Med. 116:1992;821-828.
14. O'Riordain M. G., Fearon K. C. H., Ross J. A., Rogers P., Falconer J. S., Bartolo D. C. C., Garden O. J., Carter D. C. Glutamine-supplemented total parenteral nutrition enhances T-lymphocyte response in surgical patients undergoing colorectal resection. Ann. Surg. 220:1994;212-221.
15. Furukawa S., Saito H., Fukatsu K., Hashiguchi Y., Inaba T., Lin M. T., Inoue T., Han I., Matsuda T., Muto T. Glutamine-enhanced bacterial killing by neutrophils from postoperative patients. Nutrition. 13:1997;863-869.
16. Griffiths R. D., Jones C., Allan-Palmer T. E. Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition. Nutrition. 13:1997;295-302.
17. Muraille E., Leo O. Revising the Th1/Th2 paradim. Scand. J. Immunol. 47:1998;1-9.
18. + T cell responses: The alternative approaches. Annu. Rev. Immunol. 15:1997;297-322.
19. Ravn P., Boesen H., Pedersenn B. K., Andersen P. Human T cell responses induced by vaccination with Mycobacterium bovis bacillus Calmette-Guérin. J. Immunol. 158:1997;1949-1955.
20. Borrow P., Oldstone M. B. A. Measles virus-mononuclear cell interactions. Curr. Top. Microbiol. Immunol. 191:1995;85-100.
21. Griffin D. E., Ward B. J. Differential CD4 T cell activation in measles. J. Infect. Dis. 168:1993;275-281.
22. Yang K. D., Lee C. S., Hwang K. P., Chu M. L., Shaio M. F. A model to study cytokine profiles in primary and heterogeneously secondary dengue-2 virus infections. Acta. Virol. 39:1995;19-21.
23. Yang K. D., Augustine N. H., Shaio M. F., Bohnsack J. F., Hill H. R. Effects of fibronectin on actin organization and respiratory burst activity in neutrophils, monocytes, and macrophages. J. Cell. Physiol. 158:1994;347-353.
24. Shaio M. F., Cheng S. N., Yuh Y. S., Yang K. D. Cytotoxic factors released by dengue virus-infected human blood monocytes. J. Med. Virol. 46:1995;216-223.
25. Chalmers I. M. H., Janossay G., Contreras M., Navarrete C. Intracellular cytokine profiles of cord and adult blood lymphocytes. Blood. 92:1998;11-18.
26. Mascher B., Schlenke P., Seyfarth M. Expression and kinetics of cytokines determined by intracellular staining using flow cytometry. J. Immunol. Methods. 223:1999;115-121.
27. Trinchieri G. Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-γ). Curr. Opin. Immunol. 9:1997;17-23.
28. Splittler A., Winkler S., Gotzinger P., Oehler R., Willheim M., Tempfer C., Weigel G., Fugger R., Boltz-Nitulescu G., Roth E. Influence of glutamine on the phenotype and function of human monocytes. Blood. 86:1995;1564-1569.
29. Calder P. C. Glutamine and immune system. Clin. Nutr. 13:1994;2-8.
30. Souba W. W., Wilmore D. W. Diet and nutrition in the care of the patients with surgery, trauma, and sepsis. Shils M. E., Olson J. A., Shike M. Modern Nutrition in the Health and Disease. 1994;1208-1240 Lea & Febiger, Malvern.
31. Yoshida S., Matsui M., Shirouzu Y., Fujita H., Yamana H., Shirouzu K. Effects of glutamine supplements and radiochemotherapy on systemic immune and gut barrier function in patients with advanced esophageal cancer. Ann. Surg. 227:1998;485-491.
32. Romagnani S., Parronchi P., D'Elios M. M., Romagnani P., Annunziato F., Piccinni M. P., Manetti R., Sampognaro S., Mavilia C., DeCarli M., Maggi E., Delprete G. F. An update on human Th1 and Th2 cells. Int. Arch. Allergy Immunol. 113:1997;153-156.
33. Crawford J., Cohen H. J. The essential role of l-glutamine in lymphocyte differentiation in vitro. J. Cell. Physiol. 124:1985;275-282.
34. Yamashiki M., Nishimura A., Suzuki H., Sakaguchi S., Kosaka Y. Effects of the Japanese herbal medicine "Sho-Saiko-To" (TJ-9) on in vitro interleukin 10 production by peripheral blood mononuclear cells of patients with chronic hepatitis C. Hepatology. 25:1997;1390-1397.
35. Kuby J. Antigens. Kuby J. Immunology. 1994;85-108 Freeman, New York.
36. Durez P., Abramowicz D., Gerard C., Mechelen M. V., Amraoui Z., Dubois C., Leo O., Velu T., Goldman M. In vivo induction of interleukin 10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: Differential modulation by cyclosporin A. J. Exp. Med. 177:1993;551-555.
37. 3H-thymidine in-corporation by measles infected mononuclear cells can be corrected by treatment with isoprinosine or 5-fluoro-2-deoxyuridine. Clin. Exp. Immunol. 68:1987;259-265.
38. Summer M. H., Xavier M. H., Fialho M. B., Wannmacher C. M. D., Wajner M. The influence of amino acids on mitogen-activated proliferation of human lymphocytes in vitro. Int. J. Immunopharmac. 16:1994;865-872.
39. Furst P., Albers S., Stehle P. Glutamine-containing dipeptides in parenteral nutrition. J. Parenter. Enter. Nutr. 14:1990;118S-124S.
40. Ziegler T. R., Szeszycki E. E., Estivariz C. F., Puckett A. B., Leader L. M. Glutamine: from basic science to clinical applications. Nutrition. 12:1996;S68-S70.
41. Hall J. C., Heel K., McCauley R. Glutamine. Br. J. Surg. 83:1996;305-312.